Furthermore, ER+ breast cancer was also significantly more likely to be GRM1+ (p<0.002) where 83% of ER+ tumors were also GRM1+ but only 66% of ER- tumors were GRM1+. The gene discussed is GRM1; the disease is breast carcinoma.